The BSAVA strongly supports the use of vaccination in the control of infectious disease in companion animals. It recognises that adverse reactions, including lack of efficacy may occasionally occur, but that the overall benefit/risk analysis strongly supports the continued use of vaccination to control major infectious diseases. The BSAVA strongly recommends that all animals should receive the benefit of solid protective immunity from life-threatening infectious diseases that is conferred by vaccination using licensed veterinary products.
The BSAVA strongly supports the concept that a thorough benefit/risk assessment on an individual case basis should be discussed with clients when deciding on timing of vaccination and use of particular vaccines for particular animals. The BSAVA strongly supports the concept that tailored vaccine programmes should be applied to as many animals as possible within a population to maintain the level of protective immunity within that population. The BSAVA strongly supports all scientifically valid research into the epidemiology, control and prevention of infectious diseases in the UK and the publication of such research, so as to provide veterinary surgeons with appropriate information on which to base decisions. The BSAVA strongly supports further research into improving efficacy and safety of vaccines.
The BSAVA strongly supports the importance of pharmacovigilance and the VMD Suspected Adverse Reactions Reporting Scheme.
The BSAVA strongly recommends against the use of nosode vaccines for companion animals and believes that there is no evidence base to support their efficacy.